Efficacy, Safety, and Multi-Omics Analysis of Pembrolizumab Combined with Nab-Paclitaxel and Platinum As First-Line Treatment in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Single-Arm Phase 2 Study